Skip to main content

Advertisement

Table 2 Incidence of DVT and major bleeding

From: IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics

THA/TKA drug No. patients No. DVT(%) No. bleeding(%)
THA UFH 60 6(10.0) 3(5.0)
  LMWH 64 6(9.4) 1(1.6)
  Fondaparinux 49 4(8.2) 3(6.1)
  others 41 5(12.2) 1(2.4)
TKA UFH 44 10(22.7) 5(11.4)
  LMWH 31 8(25.8) 2(6.5)
  Fondaparinux 32 4(12.5) 0(0)
  others 53 13(24.5) 5(9.4)
  1. Abbreviations: DVT; deep vein thrombosis, TKA; total knee arthroplasty, THA; total hip arthroplasty, UFH; unfractionated heparin, LMWH; low-molecular weight heparin